Clinical Trials
239 trialsTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
RAINFOL-01
Genmab
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
M.D. Anderson Cancer Center
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
AstraZeneca
OvAR-Y
Washington University School of Medicine
MIRA
University of British Columbia
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
M.D. Anderson Cancer Center
DE-01
AstraZeneca
PAM-II
University Medical Center Groningen
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
ENGOT-EN5
Karyopharm Therapeutics Inc
SAPPHIRE
Institut du Cancer de Montpellier - Val d'Aurelle
PROACTION:
PinkDx, Inc.
(CLOCS-2)
Imperial College London
FAST
Northwestern University
GYNCOG
Northwestern University
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
ROBO-GYN
Centre Oscar Lambret
PROPS GYN
Abramson Cancer Center at Penn Medicine
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
(TRUS)
Duke University
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Dana-Farber Cancer Institute
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
University of Miami
Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy
University of Tennessee Graduate School of Medicine
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
Asan Medical Center
ENDO-3
Queensland Centre for Gynaecological Cancer
OPTICS
DL Analytics
SCORE
Natera, Inc.
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Dana-Farber Cancer Institute
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
Rutgers, The State University of New Jersey
Hypofractionated Radiochemotherapy
University of Kentucky
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
PREFACE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Seagen Inc.
Image-Guided Gynecologic Brachytherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
Yuri Semenyuk Rivne Regional Clinical Hospital
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Washington University School of Medicine
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
GyneRep
University Health Network, Toronto
Diagnostic Value of Transcervical True-Cut Biopsy in Uterine Masses
Assiut University
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Icahn School of Medicine at Mount Sinai
LIBERATE
University Health Network, Toronto
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Dana-Farber Cancer Institute